
Sign up to save your podcasts
Or


SEC Commissioner Hester Peirce on being the lone dissenter in the SEC’s rejection of the Winklevoss bitcoin ETF. Rick Clemmer, President and CEO of NXP Semiconductors, on the breakup of the NXP-Qualcomm deal, and what their next plan is. Jim Anderson, CEO of SocialFlow, on Amazon and Twitter, Facebook, and the threat of slowing user growth. Ivan Cheung, CEO of Eisai, discusses the outlook for their BAN2401 Alzheimer's drug, made in partnership with Biogen, after investors were disappointed at the trials.
See omnystudio.com/listener for privacy information.
By Bloomberg3.8
381381 ratings
SEC Commissioner Hester Peirce on being the lone dissenter in the SEC’s rejection of the Winklevoss bitcoin ETF. Rick Clemmer, President and CEO of NXP Semiconductors, on the breakup of the NXP-Qualcomm deal, and what their next plan is. Jim Anderson, CEO of SocialFlow, on Amazon and Twitter, Facebook, and the threat of slowing user growth. Ivan Cheung, CEO of Eisai, discusses the outlook for their BAN2401 Alzheimer's drug, made in partnership with Biogen, after investors were disappointed at the trials.
See omnystudio.com/listener for privacy information.

977 Listeners

1,169 Listeners

2,183 Listeners

423 Listeners

970 Listeners

197 Listeners

1,039 Listeners

188 Listeners

70 Listeners

1,307 Listeners

63 Listeners

78 Listeners

30 Listeners

60 Listeners

5 Listeners

58 Listeners

233 Listeners

233 Listeners

67 Listeners

83 Listeners

77 Listeners

76 Listeners

87 Listeners

400 Listeners

18 Listeners

13 Listeners

7 Listeners

2 Listeners

115 Listeners

23 Listeners